Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

1. Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix Full Text available with Trip Pro

Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Show account info (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation J Pain Res Actions . 2021 Feb 2;14:263-271. doi: 10.2147/JPR.S284703. eCollection 2021. Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix , , , , , , Affiliations Expand Affiliations 1 Department of Obstetrics and Gynecology and Reproductive Sciences, Center for Endometriosis Research and Treatment, UC San Diego, La

2021 EvidenceUpdates

2. Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix Full Text available with Trip Pro

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health (...) at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Obstet Gynecol Actions . 2020 Sep;136(3):501-509. doi: 10.1097/AOG.0000000000003917. Health-Related Quality of Life Improvements in Patients With Endometriosis

2020 EvidenceUpdates

4. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis Full Text available with Trip Pro

, Jiang H, Guo SW. Patterns of and risk factors for recurrence in women with ovarian endometriomas. Obstet Gynecol 2007;109:1411-20. Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ 2014;348:g1752. Sinaii N, Plumb K, Cotton L, Lambert A, Kennedy S, Zondervan K, et al. Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertil Steril 2008;89:538-45. Vercellini P, Vigano P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev (...) Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily

2020 EvidenceUpdates

5. Fertility outcomes of deep infiltrating endometriosis with fertility desire——a meta analysis Full Text available with Trip Pro

are required to determine fertility outcomes according to age, endometrioma, adenomyosis, ASRM scores and so on. Keywords deep infiltrating endometriosis, fertility desire, pregnant rates, assisted reproductive technology Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Background Methods Results Discussion Conclusions Abbreviations Declarations References Tables Table1. Basic characterics of studies year of publication study characteristics number length of follow up(months (...) that the heterogeneity was not caused by fertility status ,surgical methods or study characteristics. Conclusion: Through this meta-analysis, we think that surgery combined ART or not doesn’t affect the pregnancy rate in patients with DIE. But further investigations are required to determine fertility outcomes according to age, endometrioma, adenomyosis, ASRM scores and so on. Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Background Methods Results Discussion Conclusions Abbreviations Declarations

2020 Research Square

6. Efficacy and safety of dienogest for the treatment of endometriosis and adenomyosis: a systematic review and meta-analysis Full Text available with Trip Pro

Efficacy and safety of dienogest for the treatment of endometriosis and adenomyosis: a systematic review and meta-analysis Inplasy Protocol 340 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

7. Effect of melatonin for the management of endometriosis: a protocol of systematic review and meta-analysis Full Text available with Trip Pro

Effect of melatonin for the management of endometriosis: a protocol of systematic review and meta-analysis Inplasy Protocol 115 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols

8. Painful endometriosis: initial treatment options

Painful endometriosis: initial treatment options Prescrire IN ENGLISH - Spotlight ''Painful endometriosis: initial treatment options'', 1 March 2020 {1} {1} {1} | | > > > Painful endometriosis: initial treatment options Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Painful endometriosis: initial treatment options In the absence of urinary (...) or intestinal symptoms, and if the patient is not planning to become pregnant any time soon, first try analgesics such as NSAIDs or paracetamol. Hormonal contraception or a levonorgestrel intrauterine device are other options. Endometriosis, i.e. the abnormal presence of clumps of uterine mucous membrane cells outside the uterus, is a frequent cause of pelvic pain during menstruation. In some women, endometriosis is very painful and debilitating. Endometriosis does not appear to get worse over time

2020 Prescrire

9. Videolaparoscopic Treatment of Endometriosis: A Systematic Review Full Text available with Trip Pro

, Pedro de Sousa Leite, Mondeyv de Freitas Pascoal, Francisco Felippe Araújo Rolim Abstract Endometriosis is characterized by the presence of stroma and endometrial glands in extrauterine sites, which can compromise several sites. The definitive diagnosis of endometriosis is through laparotomy or laparoscopy. The objective of the present work is to analyze and evaluate the importance of laparoscopic treatment of endometriosis in the last 5 years. The present study is a systematic review (...) , Laparoscopy, videolaparoscopy and endometriosis. Full Text: References Audebert, Alain et al. (2015). Adolescent endometriosis: report of a series of 55 cases with a focus on clinical presentation and long-term issues. Journal of minimally invasive gynecology, v. 22, n. 5, p. 834-840. Bardin. L. (1997). Análise de conteúdo. Lisboa: Editora Edições 70. Bourdel, N. et al. (2011). Surgery for the management of ovarian endometriomas: from the physiopathology to the pre-, peri-and postoperative treatment

2020 Amadeus International Multidisciplinary Journal

10. Fertility outcomes of deep infiltrating endometriosis with fertility desire—a meta analysis Full Text available with Trip Pro

rate in patients with DIE. But further investigations are required to determine fertility outcomes according to age, endometrioma, adenomyosis, ASRM scores and so on. Keywords deep infiltrating endometriosis; fertility desire; pregnant rates; assisted reproductive technology Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Background Methods Results Discussion Conclusions Abbreviations Declarations References Tables Table1. Basic characterics of studies year of publication study characteristics (...) and the heterogeneity is high. Then,we performed subgroup analysis and found that the heterogeneity was not caused by fertility status ,surgical methods or study characteristics. Conclusion: Through this meta-analysis, we think that surgery combined ART or not doesn’t effect on pregnancy rate in patients with DIE. But further investigations are required to determine fertility outcomes according to age, endometrioma, adenomyosis, ASRM scores and so on. Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Background

2020 Research Square

11. Impact of haemostatic sealant versus electrocoagulation on ovarian reserve after laparoscopic ovarian cystectomy of ovarian endometriomas: a randomised controlled trial Full Text available with Trip Pro

Impact of haemostatic sealant versus electrocoagulation on ovarian reserve after laparoscopic ovarian cystectomy of ovarian endometriomas: a randomised controlled trial To evaluate the effect of haemostatic sealant compared with bipolar coagulation on ovarian reserve after laparoscopic cystectomy for ovarian endometriomas.Patient-blinded, randomised controlled trial.University-affiliated tertiary hospital.Women aged 18-40 years with 3-8 cm unilateral or bilateral endometriomas.Ninety-four (...)  ± 4.92 years underwent laparoscopic cystectomy for ovarian endometriomas. The average diameter of the endometrioma was 4.21 ± 1.38 cm. The increase in antral follicle count of the affected ovaries at 3 months in the intervention group (+2.36 ± 0.37) was significantly (P = 0.013) higher than that in the control group (+1.08 ± 0.36). Repeated measures analysis of variance revealed significant effect with time (P < 0.001) and of interaction of group × time (P = 0.029) for affected ovary antral follicle

2019 EvidenceUpdates

12. Elagolix (Orilissa) - for the treatment of moderate to severe pain associated with endometriosis

Elagolix (Orilissa) - for the treatment of moderate to severe pain associated with endometriosis Search Page - Drug and Health Product Register Language selection Search and menus Search Search website Search Topics menu You are here: Summary Basis of Decision - - Health Canada Expand all Summary Basis of Decision (SBD) for Contact: Summary Basis of Decision (SBD) documents provide information related to the original authorization of a product. The for is located below. Recent Activity for SBDs

2019 Health Canada - Drug and Health Product Register

13. Endometriosis

Endometriosis Endometriosis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Search Select language Endometriosis Last reviewed: December 2019 Last updated: March 2019 Summary Chronic inflammatory condition defined by endometrial stroma and glands found outside of the uterine cavity. The most common sites affected are the pelvic peritoneum and ovaries. May present incidentally in asymptomatic patients, or more (...) ), and surgical destruction of lesions. Controlled ovarian hyper-stimulation and IVF may be considered for patients with sub-fertility. Individualised care for patients with pelvic pain should incorporate a multi-disciplinary evaluation and treatment plan that focuses on limiting the risk of recurrence and improving quality of life. Definition Endometriosis is defined as the presence of endometrial glands and stroma outside the endometrial cavity and uterine musculature. Surgical appearance varies

2019 BMJ Best Practice

14. Baseline severe constipation negatively impacts functional outcomes of surgery for deep endometriosis infiltrating the rectum: Results of the ENDORE randomized trial. (Abstract)

Baseline severe constipation negatively impacts functional outcomes of surgery for deep endometriosis infiltrating the rectum: Results of the ENDORE randomized trial. Predictive factors of functional outcomes after the surgery of rectal endometriosis are not well identified. Our recent randomized trial did not find significant differences between functional outcomes in patients managed by radical or conservative rectal surgery.To identify preoperative factors which determine functional outcomes (...) measures was used to assess whether a trend could be observed over the follow-up period as regards gastrointestinal and quality of life scores.60 patients with deep endometriosis infiltrating the rectum were managed by conservative surgery (27 cases) and segmental colorectal resection (33 cases). The primary endpoint was recorded in 26 patients (48.1% for conservative surgery vs. 39.4% for radical surgery, OR = 0.70, 95% CI 0.22-2.21). There was a significant improvement in values of all

2019 Journal of gynecology obstetrics and human reproduction Controlled trial quality: predicted high

15. Dysmenorrhea and Endometriosis in the Adolescent

for endometriosis in adolescents is conservative surgical therapy for diagnosis and treatment combined with ongoing suppressive medical therapies to prevent endometrial proliferation. Patients with endometriosis who have pain refractory to conservative surgical therapy and suppressive hormonal therapy often benefit from at least 6 months of gonadotropin-releasing hormone (GnRH) agonist therapy with add-back medicine. Nonsteroidal antiinflammatory drugs should be the mainstay of pain relief for adolescents (...) in adolescents requiring the presence of endometrial glands and stroma in the biopsy specimen from a location outside of the endometrial cavity. Patients with persistent dysmenorrhea despite treatment and no other identified etiologies should be counseled about the high likelihood of endometriosis and the risks and benefits of diagnostic laparoscopy. The benefits of laparoscopy include confirmation of the presence or absence of endometriosis or other causes of chronic pain such as adhesive disease

2019 American College of Obstetricians and Gynecologists

16. Transversus abdominis plane block under laparoscopic guide versus port-site local anaesthetic infiltration in laparoscopic excision of endometriosis: a double-blind randomised placebo-controlled trial (Abstract)

Transversus abdominis plane block under laparoscopic guide versus port-site local anaesthetic infiltration in laparoscopic excision of endometriosis: a double-blind randomised placebo-controlled trial To compare the efficiency of laparoscopically guided transversus abdominis plane block (LTAP) versus port-site local anaesthetic infiltration (LAI) in reducing postoperative pain following laparoscopic excision of endometriosis.A prospective, double-blind randomised controlled trial.A tertiary (...) referral centre for endometriosis and minimally invasive gynaecological surgery.Women undergoing laparoscopic excision of endometriosis from December 2015 through July 2016.Participants were randomised to receive: port-site infiltration with bupivacaine and placebo LTAP (LAI group, n = 21); placebo port-site infiltration and LTAP with bupivacaine (LTAP group, n = 24); placebo port-site infiltration and placebo LTAP (placebo group, n = 25).Post-operative pain at 2-4, 6-8, 10-12 and 24 hours, analgesic

2019 EvidenceUpdates

17. Renal Endometriosis: The Case of an Endometrial Implant Mimicking a Renal Mass Full Text available with Trip Pro

Renal Endometriosis: The Case of an Endometrial Implant Mimicking a Renal Mass Background: Endometriosis is a multifactorial benign disorder characterized by the abnormal presence of endometrial tissue in an extraendometrial site. Although extrapelvic endometriosis is uncommon, symptomatic involvement of the kidney is exceedingly rare. This benign disease can mimic several urologic processes, but because of its scarcity in clinical practice, it is seldom considered in the differential. Case (...) Presentation: In this report, we describe the case of a 45-year-old woman with flank pain and hematuria, who was found to have a left renal mass on cross-sectional imaging. After robotic partial nephrectomy, pathologic analysis revealed an endometrial implant within the renal parenchyma. Conclusion: This case of renal endometriosis highlights how this benign disease process can mimic several more sinister urologic processes.

2018 Journal of endourology case reports

18. MRI-Ultrasound Fusion Imaging for Diagnosis of Deep Infiltrating Endometriosis – A Critical Appraisal Full Text available with Trip Pro

MRI-Ultrasound Fusion Imaging for Diagnosis of Deep Infiltrating Endometriosis – A Critical Appraisal It was the aim of our study to evaluate this procedure using pelvic anatomical landmarks in order to assess the accuracy of fusion imaging and to critically evaluate the applicability in daily practice.In a prospective, single center study, 10 patients with clinical signs of deep infiltrating endometriosis (DIE) were selected. We measured the distance between the landmark organ and the target

2018 Ultrasound international open

19. Large-scale genome-wide association meta-analysis of endometriosis reveals 13 novel loci and genetically-associated comorbidity with other pain conditions Full Text available with Trip Pro

Large-scale genome-wide association meta-analysis of endometriosis reveals 13 novel loci and genetically-associated comorbidity with other pain conditions Large-scale genome-wide association meta-analysis of endometriosis reveals 13 novel loci and genetically-associated comorbidity with other pain conditions | bioRxiv Search for this keyword New Results Large-scale genome-wide association meta-analysis of endometriosis reveals 13 novel loci and genetically-associated comorbidity with other pain (...) , Whiteman David , Becker M Christian , Salumets Andres , Magi Reedik , Kraft Peter , Nyegaard Mette , Nyholt R Dale , Steinthorsdottir Valgerdur , Stefansson Kari , Velez-Edwards R Digna , Yurttas Beim Piraye , Missmer A Stacey , Montgomery W Grant , Morris P Andrew , Zondervan T Krina doi: https://doi.org/10.1101/406967 Rahmioglu Nilufer 1 Wellcome Centre for Human Genetics, University of Oxford , Oxford, UK . 2 Oxford Endometriosis CaRe Centre, Nuffield Department of Women’s and Reproductive Health

2018 Cold Spring Harbor Laboratory

20. Elagolix sodium (Orilissa) - For the management of moderate to severe pain associated with endometriosis

Elagolix sodium (Orilissa) - For the management of moderate to severe pain associated with endometriosis Drug Approval Package: Orilissa (elagolix sodium) U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: Orilissa (elagolix sodium) Company: AbbVie Inc. Application Number: 210450 Approval Date: 07/23/2018 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF

2018 FDA - Drug Approval Package